Van Andel研究所的研究人员开发了更有效的早期胰腺癌血液测试。 Researchers at Van Andel Institute developed a more effective early-stage pancreatic cancer blood test.

Van Andel研究所的研究人员开发了有希望的血液测试,比现有方法更有效地检测早期胰腺癌。 Researchers at the Van Andel Institute have developed a promising blood test that detects early-stage pancreatic cancer more effectively than existing methods. 通过合并CA199.STRA和CA19-9这两个生物标志,测试提高了检测准确度27%,在实验室测试中确定了71%的胰腺癌样本。 By combining two biomarkers, CA199.STRA and CA19-9, the test improved detection accuracy by 27%, identifying 71% of pancreatic cancer samples in lab tests. 下一阶段涉及临床评估,因为早期发现对于提高存活率至关重要。 The next phase involves clinical evaluations, as early detection is crucial for improving survival rates.